ScienceCrossing the borders of innovationBasing clinical trials on sound mechanistic and scientific rationale.Combating Pan-Cancer with PrecisionCombating Pan-Cancer with PrecisionSaving Lives of Patients Who Exhausted Treatment Options and Improving Clinical BenefitsPatient no boxCancer Patients are fighting for their lives...we will fight with themImagining a world without cancer. Apollomics是一家致力于发现和开发肿瘤组合疗法的创新型生物制药公司。 管道 科学 活动 我们的愿景 成为癌症患者新型药物开发的全球领导者。 学到更多 最近的新闻 September 22, 2025 Apollomics Announces Receipt of Nasdaq Delisting Notification, and Will Appeal to Retain November 16, 2023 Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer 更多新闻
